📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: TypeZero

1.1 - Company Overview

TypeZero Logo

TypeZero

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of digital health and personalized medicine focused on the treatment and management of diabetes, leveraging more than 10 years of clinical trials, research, and innovation to develop the inControl Diabetes Management Platform to improve and simplify the lives of people with diabetes.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to TypeZero

CytoTools Logo

CytoTools

HQ: Germany Website
  • Description: Provider of unique biotechnology therapies derived from fundamental biology research on cell growth and programmed cell death, designed to treat the causes of disease rather than the symptoms.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CytoTools company profile →
Intarcia Logo

Intarcia

HQ: United States Website
  • Description: Provider of long-term therapies for chronic diseases, offering the MEDICITM Drug Delivery System for twice-yearly subcutaneous osmotic implants, ITCA 650 (twice-yearly exenatide implant) for type 2 diabetes, and an Ionic Liquid Platform converting injectable biologics and peptides into oral therapies; pipeline includes i2o-105s (long-acting GLP-1 receptor agonist), i2o-107 (long-acting amylin), and i2o-110 (dual agonist) for type 2 diabetes, obesity, and NASH.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Intarcia company profile →
Thermalin Logo

Thermalin

HQ: United States Website
  • Description: Provider of insulins and delivery systems that transform the economic, treatment, and disease management paradigms for diabetes.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Thermalin company profile →
Vitae Pharmaceuticals Logo

Vitae Pharmaceuticals

HQ: United States Website
  • Description: Provider of clinical-stage biopharmaceutical therapies, building a portfolio of novel, best-in-class small molecules and biologics addressing significant unmet needs, including chronic kidney disease, diabetes, atherosclerosis, and Alzheimer’s. Programs span immunology, oncology, neuroscience, eye care, aesthetics, and patient access and support.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Vitae Pharmaceuticals company profile →
Beta Bionics Logo

Beta Bionics

HQ: United States Website
  • Description: Provider of software to reduce the burden of diabetes care, offering the iLet Bionic Pancreas, an insulin delivery system that autonomously manages and administers insulin doses based on continuous glucose monitoring data, with Dexcom G7 CGM integration for real-time dose adjustments and compatibility with prefilled insulin cartridges for convenience and choice among insulin types.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Beta Bionics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for TypeZero

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to TypeZero

2.2 - Growth funds investing in similar companies to TypeZero

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for TypeZero

4.2 - Public trading comparable groups for TypeZero

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to TypeZero

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About TypeZero

What does TypeZero do?

TypeZero is a provider of digital health and personalized medicine focused on the treatment and management of diabetes, leveraging more than 10 years of clinical trials, research, and innovation to develop the inControl Diabetes Management Platform to improve and simplify the lives of people with diabetes.

Who are TypeZero's competitors?

TypeZero's competitors and similar companies include CytoTools, Intarcia, Thermalin, Vitae Pharmaceuticals, and Beta Bionics.

Where is TypeZero headquartered?

TypeZero is headquartered in United States.

How many employees does TypeZero have?

TypeZero has 1,000 employees 🔒.

When was TypeZero founded?

TypeZero was founded in 2010 🔒.

What sector and industry vertical is TypeZero in?

TypeZero is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for TypeZero

Who are the top strategic acquirers in TypeZero's sector and industry

Top strategic M&A buyers and acquirers in TypeZero's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for TypeZero?

Top strategic M&A buyers groups and sectors for TypeZero include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in TypeZero's sector and industry vertical

Which are the top PE firms investing in TypeZero's sector and industry vertical?

Top PE firms investing in TypeZero's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in TypeZero's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in TypeZero's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in TypeZero's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to TypeZero include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in TypeZero's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for TypeZero?

The key public trading comparables and valuation benchmarks for TypeZero include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for TypeZero for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for TypeZero with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in TypeZero's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for TypeZero with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in TypeZero's' sector and industry vertical?

Access recent funding rounds and capital raises in TypeZero's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for TypeZero